Bromelain‐Rich Pineapple Extract for the Treatment of Pediatric Patients With Orchiepididymitis : A Randomized Clinical Pilot Study
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70148 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Alessandro Colletti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Science and Technology, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Bromelains, Ananas, Plant Extracts, Epididymitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Turin, Università degli Studi di Torino.
Abstract (Originalsprache)
A freeze‐dried pineapple extract—Brome‐Inf, from pineapple by‐products of industrial rings production, was enriched in bioactive polypeptides and bromelain by membrane ultrafiltration. Orchiepididymitis (OE), a painful pediatric pathology, was treated with this extract. A pilot, double‐blind, randomized study involving 60 pediatric OE patients compared the effects of Brome‐Inf to a placebo over a 15‐day period, in conjunction with antibiotic treatment. In the present study, the primary objective was to assess the disparity in NSAIDs usage and pain intensity between the Brome‐Inf group and the placebo group, utilizing the Wong‐Becker, Numerical Rating Scale (NRS), and Visual Analogue Scale (VAS) pain rating scales. Results revealed a significant reduction in VAS and NRS within the Brome‐Inf group from Days 1 to 15 compared with placebo. A rapid regression of edema was observed in the active group after 1 week and at the end of the study. We can conclude that oral supplementation with Brome‐Inf emerges as a promising co‐management option for OE for its action on pain and edema, potentially enhancing the quality of life for affected children. Importantly, due to its well‐balanced fruity flavor, the palatability of Brome‐Inf was appreciated, ensuring optimal patient compliance and treatment safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Science and Technology, University of Turin, Turin, Italy.
- Italian Society of Nutraceutical Formulators (SIFNut), Treviso, Italy.
- SS. Antonio and Biagio and Cesare Arrigo Hospital, Alessandria, Italy.
- Department of Pharmacy, University of Pisa, Pisa, Italy.
ORCID-Profile: Giancarlo Cravotto
Förderung
- University of Turin
- Università degli Studi di Torino
Zitieren
APA
Colletti, A., Sangiorgio, L., Martelli, A., Pellizzato, M., & Cravotto, G. (2025). Bromelain‐Rich Pineapple Extract for the Treatment of Pediatric Patients With Orchiepididymitis : A Randomized Clinical Pilot Study. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70148
Vancouver
Colletti A, Sangiorgio L, Martelli A, Pellizzato M, Cravotto G. Bromelain‐Rich Pineapple Extract for the Treatment of Pediatric Patients With Orchiepididymitis : A Randomized Clinical Pilot Study. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70148
BibTeX
@article{Colletti2025,
author = {Colletti, Alessandro and Sangiorgio, Luciano and Martelli, Alma and Pellizzato, Marzia and Cravotto, Giancarlo},
title = {Bromelain‐Rich Pineapple Extract for the Treatment of Pediatric Patients With Orchiepididymitis : A Randomized Clinical Pilot Study},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70148}
}
EUVIMED